BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38657377)

  • 1. Predicting peritoneal recurrence after radical gastrectomy for gastric cancer: Validation of a prediction model (PERI-Gastric 1 and PERI-Gastric 2) on a Korean database.
    Belia F; Kim KY; Agnes A; Park SH; Cho M; Kim YM; Kim HI; Persiani R; D'Ugo D; Biondi A; Hyung WJ
    Eur J Surg Oncol; 2024 Jun; 50(6):108359. PubMed ID: 38657377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the PERI-Gastric (PEritoneal Recurrence Index) and PERI-Gram (Peritoneal Recurrence Index NomoGRAM) for predicting the risk of metachronous peritoneal carcinomatosis after gastrectomy with curative intent for gastric cancer.
    Agnes A; Biondi A; Persiani R; Laurino A; Reddavid R; De Giuli M; Sicoli F; Cananzi F; De Pascale S; Fumagalli U; Galli F; Rausei S; Lorenzon L; D'Ugo D
    Gastric Cancer; 2022 May; 25(3):629-639. PubMed ID: 34811622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer.
    Bencivenga M; Verlato G; Han DS; Marrelli D; Roviello F; Yang HK; de Manzoni G;
    Br J Surg; 2017 Aug; 104(9):1235-1243. PubMed ID: 28489249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the PERI-Gastric (PEritoneal Recurrence Index) and PERI-Gram (Peritoneal Recurrence Index NomoGRAM) for predicting the risk of metachronous peritoneal carcinomatosis after gastrectomy with curative intent for gastric cancer: a methodology issue.
    Zhang WL; Cui T
    Gastric Cancer; 2022 Nov; 25(6):1129-1130. PubMed ID: 36056986
    [No Abstract]   [Full Text] [Related]  

  • 5. Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy.
    Wang SB; Qi WX; Chen JY; Xu C; Kirova YM; Cao WG; Cai R; Cao L; Yan M; Cai G
    Radiat Oncol; 2019 Jul; 14(1):128. PubMed ID: 31315683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomogram to predict overall survival of patients receiving radical gastrectomy and incomplete peri-operative adjuvant chemotherapy for stage II/III gastric cancer: a retrospective bi-center cohort study.
    Liu D; Quan H; Ma M; Zhou H; Yang X; Wu Z; Luo J; Xiao H; Xiao Y
    BMC Cancer; 2024 Mar; 24(1):344. PubMed ID: 38500085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence.
    Yoo C; Ryu MH; Park YS; Yoo MW; Park SR; Ryoo BY; Jang SJ; Yook JH; Kim BS; Kang YK
    Ann Surg Oncol; 2015 Sep; 22(9):2940-7. PubMed ID: 25605515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
    Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
    Front Immunol; 2021; 12():651033. PubMed ID: 34054812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic Profiling Identifies a Risk Stratification Signature for Predicting Peritoneal Recurrence and Micrometastasis in Gastric Cancer.
    Lee IS; Lee H; Hur H; Kanda M; Yook JH; Kim BS; Woo Y; Kodera Y; Kim K; Goel A
    Clin Cancer Res; 2021 Apr; 27(8):2292-2300. PubMed ID: 33558424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-C motif chemokine 22 ligand (CCL22) concentrations in sera of gastric cancer patients are related to peritoneal metastasis and predict recurrence within one year after radical gastrectomy.
    Wei Y; Wang T; Song H; Tian L; Lyu G; Zhao L; Xue Y
    J Surg Res; 2017 May; 211():266-278. PubMed ID: 28501127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
    Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
    [No Abstract]   [Full Text] [Related]  

  • 12. Predicting Peritoneal Metastasis of Gastric Cancer Patients Based on Machine Learning.
    Zhou C; Wang Y; Ji MH; Tong J; Yang JJ; Xia H
    Cancer Control; 2020; 27(1):1073274820968900. PubMed ID: 33115287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European validation of the Yonsei Gastric Cancer Prognosis Prediction Model after gastrectomy: Validation with the Netherlands Cancer Registry.
    Brenkman HJF; Cho M; Ruurda JP; Song K; Son T; Kim HI; Noh SH; van Hillegersberg R; Hyung WJ
    Eur J Surg Oncol; 2019 Jun; 45(6):983-988. PubMed ID: 30654921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study.
    Jiang Y; Zhang Z; Yuan Q; Wang W; Wang H; Li T; Huang W; Xie J; Chen C; Sun Z; Yu J; Xu Y; Poultsides GA; Xing L; Zhou Z; Li G; Li R
    Lancet Digit Health; 2022 May; 4(5):e340-e350. PubMed ID: 35461691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram to predict prolonged postoperative ileus after gastrectomy in gastric cancer.
    Liang WQ; Zhang KC; Cui JX; Xi HQ; Cai AZ; Li JY; Liu YH; Liu J; Zhang W; Wang PP; Wei B; Chen L
    World J Gastroenterol; 2019 Oct; 25(38):5838-5849. PubMed ID: 31636476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological tumor infiltrative pattern and sites of initial recurrence in stage II/III gastric cancer: Propensity score matching analysis of a multi-institutional dataset.
    Nakagawa N; Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
    Cancer Med; 2018 Dec; 7(12):6020-6029. PubMed ID: 30411544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting recurrence after curative resection for gastric cancer: External validation of the Italian Research Group for Gastric Cancer (GIRCG) prognostic scoring system.
    Barchi LC; Yagi OK; Jacob CE; Mucerino DR; Ribeiro U; Marrelli D; Roviello F; Cecconello I; Zilberstein B
    Eur J Surg Oncol; 2016 Jan; 42(1):123-31. PubMed ID: 26365755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration.
    Chang JS; Kim KH; Keum KC; Noh SH; Lim JS; Kim HS; Rha SY; Lee YC; Hyung WJ; Koom WS
    J Surg Oncol; 2016 Dec; 114(7):859-864. PubMed ID: 27511744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laparoscopic diagnosis of postoperative recurrence of peritoneal metastasis in gastric cancer patients and the clinical efficacy of bidirectional intraperitoneal and systemic chemotherapy].
    Yan C; Yang ZY; Shi M; Xu W; Ni ZT; Hua ZC; Liu WT; Zhu ZL; Bi RD; Zheng YN; Feng RH; Yao XX; Chen MM; Li C; Zhang J; Yan M; Zhu ZG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):492-498. PubMed ID: 32842430
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy.
    Bilici A; Selcukbiricik F
    Tumour Biol; 2015 Aug; 36(8):6191-9. PubMed ID: 25761877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.